Annals of Emergency Medicine
Volume 45, Issue 1 , Pages 27-31 , January 2005

One resident perspective: Resident education and the pharmaceutical industry: One resident perspective: Resident education and the pharmaceutical industry

  • Corita R. Grudzen, MD

      Affiliations

    • Corresponding Author InformationAddress for correspondence: Corita R. Grudzen, MD, Department of Emergency Medicine, Bellevue Hospital Center, 1st Avenue and 27th Street, New York, NY 10016; 917-204-5855, fax 718-381-9057

References 

  1. American College of Emergency Physicians. Background regarding gifts to emergency physicians from the biomedical industry (June 1993). Available at: http://www.acep.org/1,574,0.html. Accessed August 20, 2004.
  2. American College of Physicians . Physicians and the pharmaceutical industry. Ann Intern Med. 1990;112:624–626
  3. American Medical Association . Ethical Opinion/Guidelines. E-Addendum II: Council on Ethical and Judicial Affairs, Clarification of “Gifts to Physicians from Industry” Opinion E-8.061. Chicago, IL: American Medical Association; 1992;
  4. American College of Emergency Physicians. Gifts to emergency physicians from the biomedical industry [policy statement]. Available at: http://www.acep.org/1,575,0.html. Accessed August 20, 2004.
  5. Sanders AB, Keim SM, Sklar D, et al. Emergency physicians and the biomedical industry. Ann Emerg Med. 1992;21:556–558Available at: http://www.saem.org/download/industry.pdfAccessed August 20, 2004
  6. Ross B, Scott DW. Influencing doctors. How pharmaceutical companies use enticement to “educate” physicians (February 21, 2002). ABC News. Available at: http://www.whale.to/v/bribe.html. Accessed November 15, 2004.
  7. CTV news staff. Just say no (May 17, 2002). CTV News. Available at: http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/1024857406494_20266606/. Accessed August 20, 2004.
  8. Harris G. Medical marketing—Treatment by incentive; As doctor writes prescription, drug company writes a check. The New York Times. June 27, 2004;Section 1:1. Available at: http://query.nytimes.com/gst/abstract.html?res=F50612FC3C5C0C748EDDAF0894DC404482. Accessed August 18, 2004.
  9. British Medical Association Web site. Incentives to GPs for referral or prescribing. (September 1995, Revised January 1997). Available at: http://web.bma.org.uk/ap.nsf/Content/incentives+to+GPs+for+referral+or+prescribing. Accessed August 20, 2004.
  10. American College of Physicians . Position papers: ethics manual: fourth edition. Ann Intern Med. 1998;128:576–594
  11. Mainous AG, Hueston WJ, Rich EC. Patient perceptions of physician acceptance of gifts from the pharmaceutical industry. Arch Fam Med. 1995;4:335–339
  12. Gibbons RV, Landry FJ, Blouch DL, et al. A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts. J Gen Int Med. 1998;13:151–154
  13. Accreditation Council for Graduate Medical Education. Principles to guide the relationship between graduate medical education and industry (adopted September 2002). Available at: http://www.acgme.org/New/GMEGuide.pdf. Accessed August 2, 2004.
  14. Keim S, Perina DG. Council of Emergency Medicine Residency Directors position on interactions between emergency medicine residencies and the pharmaceutical industry. Acad Emerg Med. 2004;11:78
  15. PhRMA Code on Interactions with Medical Professionals (adopted July 1, 2002). Available at:/http://www.phrma.org/publications/policy//2004-01-19.391.pdf. Accessed August 2004.
  16. McCormick BB, Tomlinson G, Brill-Edwards P, et al. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA. 2001;286:1994–1999
  17. Lichstein PR, Turner RC, O'Brien K. Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors. Archiv Int Med. 1992;152:1009–1013
  18. Keim SM, Mays MZ, Grant D. Interactions between emergency medicine programs and the pharmaceutical industry. Acad Emerg Med. 2004;11:19–26
  19. Reeder M, Dougherty J, White LJ. Pharmaceutical representatives and emergency medicine residents: a national survey. Ann Emerg Med. 1993;22:1593–1596
  20. Watkins RS, Kimberly J. What residents don't know about physician-pharmaceutical interactions. Acad Med. 2004;79:432–437
  21. Chren MM, Landefeld CS. Physicians' behavior and their interactions with drug companies: a controlled study of physicians who requested additions to a hospital drug formulary. JAMA. 1994;272:684–689
  22. Orlowski JP, Wateska L. The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch. Chest. 1992;102:270–273
  23. Gill KS, Katz ED, Mahoney H. Effect of pharmaceutical representatives on prescribing practices of an emergency medicine residency. [abstract] Acad Emerg Med. 2003;10:424
  24. Holmer AF. Industry strongly supports medical education. JAMA. 2001;285:2012–2015
  25. Villanueva P, Peiro S, Librero J, et al. Accuracy of pharmaceutical advertisements in medical journals. Lancet. 2003;361:27–32
  26. Ziegler MG, Lew P, Singer BC. The accuracy of drug information from pharmaceutical sales representatives. JAMA. 1995;273:1296–1298
  27. Angell M. Time for a drug test registry. The Washington Post. August 13, 2004.
  28. Harris G. Spitzer sues a drug maker, saying it hid negative data. The New York Times. June 3, 2004;Sect A:1. Available at: http://query.nytimes.com/gst/abstract.html?res=F00F14FA3E550C708CDDAF0894DC404482. Accessed August 20, 2004.
  29. Lo B. Resolving Ethical Dilemmas: A Guide for Clinicians. Baltimore, MD: Williams & Wilkins; 1995;
  30. Sidorov J. How are internal medicine residency journal clubs organized and what makes them successful?. Arch Int Med. 1995;155:1193–1197
  31. Nasca TJ, Veloski JJ, Monnier JA, et al. Minimum instructional and program-specific administrative costs of educating residents in internal medicine. Arch Intern Med. 2001;161:760–766
  32. Iglehart JK. Medicare and graduate medical education. N Engl J Med. 1998;338:402–407
  33. Coyle SL. Physician-industry relations. Part 1: individual physicians. Ann Intern Med. 2002;136:396–402
  34. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift?. JAMA. 2000;283:373–380
  35. American Medical Student Association's PharmFree Medical Student Pledge. Available at: http://www.amsa.org/prof/pledge.cfm. Accessed August 2004.

 The author reports this study did not receive any outside funding or support.Reprints not available from the author.

PII: S0196-0644(04)01463-5

doi: 10.1016/j.annemergmed.2004.09.018

Annals of Emergency Medicine
Volume 45, Issue 1 , Pages 27-31 , January 2005